Peptide
KPV
Lys-Pro-Val, Alpha-MSH C-terminal tripeptide
Research ChemicalAnimal StudiesOral or Injection (SubQ)
Half-life
Unknown
Common dose
500mcg-1mg/day oral or 100-200mcg SubQ
How it works
C-terminal tripeptide of alpha-MSH. Anti-inflammatory via MC1R activation. Particularly effective at reducing intestinal inflammation — studied for IBD and Crohn's disease.
Commonly used for
Gut healthInflammationSkin conditionsIBD
Potential benefits
- Potent anti-inflammatory specifically in the gut
- Oral bioavailability — survives stomach acid
- Studied for Crohn's disease, colitis, and IBS
- Anti-microbial properties against Staph and Candida
- Wound healing at local injection sites
Risks and downsides
- Limited human clinical trial data
- Oral dosing requires higher amounts than injection
- Research Chemical status
- Effects are subtle — more preventative than acute
- Often overshadowed by BPC-157 for gut applications
Heads up: This is for educational purposes only and is not medical advice. Many compounds here are not FDA approved for human use. Please talk to a doctor before starting anything.
Risk level
Evidence
What you need to get started
Community experiences
Been there?
Sign in to share your experience with the community.
Loading reviews...